Donaldson Company

DCINYSEUSD

THESIS ALERT

Email me when the DCI thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$87.85
+$0.50 (+0.57%)Today 1M +1.06%
After hours$87.850.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$87.35
Prior regular-session close from the quote source.
$86.87–$88.15
Regular-session low and high so far today.
668.7K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Dec 3 projected
Projected for 2026-12-03 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$79.61–$112.84
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own DCI if Donaldson turns durable, technology-led filtration products (PowerCore, Ultra-Web and a global manufacturing footprint) into recurring OEM and aftermarket sales, producing steady revenue, resilient margins and free cash flow that fund M&A and shareholder returns.

DCI price history

Latest price$87.85Today+$0.50 (+0.57%)
DCI +0.34%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Donaldson's OEM relationships and recurring aftermarket replacement demand will keep consolidated revenue growing steadily and limit cyclicality, because customers require certified, reliable filtration solutions and replacement intervals create recurring purchases.StrengtheningMateriality: High

    revenue rose from 3,430,800,000 (FY2023) to 3,885,600,000 (FY2026) showing multi-year top-line growth. If true, shareholders get predictable revenue and cash conversion; if false (OEM/customer share loss or commoditization), sales and forecasts will be volatile and multiple will re-rate down.

    Watch: A material OEM sourcing decision awarding global supply to a rival (e.g., competitor consolidation wins key OEM contracts) that cuts Donaldson's OEM volumes.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    revenue rose from 3,430,800,000 (FY2023) to 3,885,600,000 (FY2026) showing multi-year top-line growth.

    Open source ↗
  • Proprietary media and product technologies (PowerCore, Ultra-Web) enable a pricing premium and efficiency that protect gross margins versus commoditized filters, because OEMs and end-users value higher-performance compact or high-temperature media.StrengtheningMateriality: High

    gross_profit grew from 1,160,600,000 (FY2023) to 1,345,900,000 (FY2026), implying margin stability while revenue rose. If maintained, gross margin resilience allows operating leverage and cash flow generation even if revenue growth is moderate; if competitors match or IP erodes, gross margins will compress.

    Watch: Emergence of lower-cost filtration media/technologies that match performance at lower price.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    gross_profit grew from 1,160,600,000 (FY2023) to 1,345,900,000 (FY2026), implying margin stability while revenue rose.

    Open source ↗
  • Donaldson's global manufacturing footprint and diversified end markets will preserve operating cash flow through cycles and enable deployment into acquisitions and shareholder returns, because geographic and end-market diversification smooths demand swings and lowers supply-cost exposure.HoldingMateriality: Medium

    operating_cash_flow has been steady: 544,500,000 (FY2023), 492,500,000 (FY2024), 493,700,000 (FY2026). Sustained operating cash flow funds M&A and buybacks without levering the balance sheet; if supply-chain shocks or tariffs persist, cash flow will be pressured and financing options constrained.

    Watch: Worsening trade barriers or reinstatement of tariffs that increase costs materially (MD&A highlights tariff risk and IEEPA refund uncertainty).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_cash_flow has been steady: 544,500,000 (FY2023), 492,500,000 (FY2024), 493,700,000 (FY2026).

    Open source ↗
  • If Donaldson executes targeted acquisitions into higher-margin Life Sciences and advanced-membrane areas at disciplined prices and integrates them successfully, operating income and operating margins will expand, because the company can scale technology, cross-sell and realize synergies.HoldingMateriality: Medium

    operating_income increased from 480,200,000 (FY2023) to 599,900,000 (FY2026). Successful M&A would re-rate the business to a faster-growth, higher-margin profile; failed or overpriced deals would dilute returns and compress margins.

    Watch: Overpaying for acquisitions or failing to integrate (resulting in lower incremental margins).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_income increased from 480,200,000 (FY2023) to 599,900,000 (FY2026).

    Open source ↗
  • Donaldson will continue converting operating profits into shareholder value (dividends/buybacks) such that diluted EPS grows over time, because stable net income and cash flow permit recurring returns and measured share count management.StrengtheningMateriality: Medium

    eps_diluted rose from 2.90 (FY2023) to 3.85 (FY2026), indicating historical EPS growth. If true, EPS-driven returns support valuation and total shareholder return; if the company issues equity for M&A or earnings weaken, EPS will stall or decline.

    Watch: Large, dilutive equity issuance to fund acquisitions or sustained earnings pressure from margin compression.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    eps_diluted rose from 2.90 (FY2023) to 3.85 (FY2026), indicating historical EPS growth.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Donaldson's OEM relationships and recurring aftermarket replacement demand will keep consolidated revenue growing steadily and limit cyclicality, because customers require certified, reliable filtration solutions and replacement intervals create recurring purchases. If true, shareholders get predictable revenue and cash conversion; if false (OEM/customer share loss or commoditization), sales and forecasts will be volatile and multiple will re-rate down.

Proprietary media and product technologies (PowerCore, Ultra-Web) enable a pricing premium and efficiency that protect gross margins versus commoditized filters, because OEMs and end-users value higher-performance compact or high-temperature media. If maintained, gross margin resilience allows operating leverage and cash flow generation even if revenue growth is moderate; if competitors match or IP erodes, gross margins will compress.

Donaldson's global manufacturing footprint and diversified end markets will preserve operating cash flow through cycles and enable deployment into acquisitions and shareholder returns, because geographic and end-market diversification smooths demand swings and lowers supply-cost exposure. Sustained operating cash flow funds M&A and buybacks without levering the balance sheet; if supply-chain shocks or tariffs persist, cash flow will be pressured and financing options constrained.

If Donaldson executes targeted acquisitions into higher-margin Life Sciences and advanced-membrane areas at disciplined prices and integrates them successfully, operating income and operating margins will expand, because the company can scale technology, cross-sell and realize synergies. Successful M&A would re-rate the business to a faster-growth, higher-margin profile; failed or overpriced deals would dilute returns and compress margins.

Donaldson will continue converting operating profits into shareholder value (dividends/buybacks) such that diluted EPS grows over time, because stable net income and cash flow permit recurring returns and measured share count management. If true, EPS-driven returns support valuation and total shareholder return; if the company issues equity for M&A or earnings weaken, EPS will stall or decline.

All standing thesis claims
Original report summary

Donaldson turns durable, technology-led filtration products (PowerCore, Ultra-Web and a global manufacturing footprint) into recurring OEM and aftermarket sales, producing steady revenue, resilient margins and free cash flow that fund M&A and shareholder returns.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for DONALDSON Co

Where the evidence on DONALDSON Co stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Donaldson's OEM relationships and recurring aftermarket replacement demand will keep consolidated revenue growing steadily and limit cyclicality, because customers require certified, reliable filtration solutions and replacement intervals create recurring purchases.

    sec.gov ↗

  • Proprietary media and product technologies (PowerCore, Ultra-Web) enable a pricing premium and efficiency that protect gross margins versus commoditized filters, because OEMs and end-users value higher-performance compact or high-temperature media.

    sec.gov ↗

  • Donaldson's global manufacturing footprint and diversified end markets will preserve operating cash flow through cycles and enable deployment into acquisitions and shareholder returns, because geographic and end-market diversification smooths demand swings and lowers supply-cost exposure.

    sec.gov ↗

  • If Donaldson executes targeted acquisitions into higher-margin Life Sciences and advanced-membrane areas at disciplined prices and integrates them successfully, operating income and operating margins will expand, because the company can scale technology, cross-sell and realize synergies.

    sec.gov ↗

  • Donaldson will continue converting operating profits into shareholder value (dividends/buybacks) such that diluted EPS grows over time, because stable net income and cash flow permit recurring returns and measured share count management.

    sec.gov ↗

Bear case: what would count against it

  • A material OEM sourcing decision awarding global supply to a rival (e.g., competitor consolidation wins key OEM contracts) that cuts Donaldson's OEM volumes.

    sec.gov ↗

  • Emergence of lower-cost filtration media/technologies that match performance at lower price.

    sec.gov ↗

  • Worsening trade barriers or reinstatement of tariffs that increase costs materially (MD&A highlights tariff risk and IEEPA refund uncertainty).

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · DONALDSON Co

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed DONALDSON Co’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    DONALDSON Co filed an SEC 8-K on 2026-10-29: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    DONALDSON Co filed an SEC 8-K on 2026-08-26: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Director or principal officer change.

    DONALDSON Co filed an SEC 8-K on 2026-07-24: Director or principal officer change. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A material OEM sourcing decision awarding global supply to a rival (e.g., competitor consolidation wins key OEM contracts) that cuts Donaldson's OEM volumes.
  • Emergence of lower-cost filtration media/technologies that match performance at lower price.
  • Worsening trade barriers or reinstatement of tariffs that increase costs materially (MD&A highlights tariff risk and IEEPA refund uncertainty).
  • Overpaying for acquisitions or failing to integrate (resulting in lower incremental margins).
  • Large, dilutive equity issuance to fund acquisitions or sustained earnings pressure from margin compression.

DCI news

Loading headlines…

Financial statements

DCI income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

DCI: quick answers

When does DONALDSON Co (DCI) report earnings next?
DONALDSON Co's next results are projected for December 3, 2026, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on August 26, 2026. Earnings calendar
What is DCI's short interest?
As of October 30, 2026, 3.3M DCI shares were sold short, 2.88% of its shares outstanding, up 1.9% from the count before. At the stock's average daily volume that is 6.4 days to cover. FINRA publishes the count twice a month. DCI short interest history
Have members of Congress traded DCI?
27 trades in DCI have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed DCI trade
Which well-known investors own DCI?
1 of the 37 well-known funds tracked here reported DCI shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

DCI in well-known investors’ portfolios

1 of 37 funds reported DCI shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.01%$1.4MNewQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.